A pseudovirus nanoparticle-based trivalent rotavirus vaccine candidate elicits high and cross p type immune response

HIGHLIGHTS

  • who: Ming Xia et al. from the Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USADepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA have published the paper: A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response, in the Journal: Pharmaceutics 2022, 14, 1597. of 30/07/2022
  • what: The main reason for this improvement was that the vast majority of the co-precipitated bacterial proteins by ammonium sulfate did not bind or bound only weakly to the ion exchange column . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?